Literature DB >> 12171959

Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression.

I N Farstad1, F-E Johansen, L Vlatkovic, J Jahnsen, H Scott, O Fausa, A Bjørneklett, P Brandtzaeg, T S Halstensen.   

Abstract

BACKGROUND: Refractory sprue is defined as primary or secondary failure to respond to a gluten free diet in patients with coeliac disease-like enteropathy and may signify cryptic or overt enteropathy associated T cell lymphoma. AIMS: To study in detail jejunal morphology and immunophenotypes in patients with refractory sprue in the search for features that might be useful to predict prognosis. PATIENTS: Seven patients are described, representing all such cases identified in our hospital over a 13 year period.
METHODS: Biopsy and/or surgical resection specimens were examined by morphology, immunohistochemistry, including enzymatic and immunofluorescent detection, and molecular biology.
RESULTS: All patients had phenotypically abnormal intraepithelial lymphocytes (IELs) that lacked CD8, T cell receptor alpha beta (or gamma delta), and/or expressed CD30 in addition to variable expression of the natural killer cell receptor CD94. A monoclonal T cell population was present in six cases, data from the seventh being inconclusive. Three patients had overt lymphoma with CD30+ tumour tissue intervening between intact mucosa that contained neoplastic IELs. Intriguingly, CD30+ IELs were observed both a long way away from, and in direct continuity with, the tumours in these patients. Such CD30+ cells were hardly detected in patients without tumours, two of which are in good health several years after the initial diagnosis.
CONCLUSIONS: Our data suggest that abnormal IELs in patients with refractory sprue are phenotypically heterogeneous. CD30 expression by these cells may indicate a worse prognosis, including the occurrence of overt lymphoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171959      PMCID: PMC1773363          DOI: 10.1136/gut.51.3.372

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  28 in total

Review 1.  Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes.

Authors:  P Brandtzaeg; T S Halstensen; K Kett; P Krajci; D Kvale; T O Rognum; H Scott; L M Sollid
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

2.  Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease.

Authors:  T S Halstensen; H Scott; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1989-12       Impact factor: 3.487

3.  Low-grade intestinal lymphoma of intraepithelial T lymphocytes with concomitant enteropathy-associated T cell lymphoma: case report suggesting a possible histogenetic relationship.

Authors:  G C Alfsen; K Beiske; H Bell; P F Marton
Journal:  Hum Pathol       Date:  1989-09       Impact factor: 3.466

Review 4.  Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.

Authors:  R Drews; A Samel; M E Kadin
Journal:  Semin Cutan Med Surg       Date:  2000-06

5.  Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment.

Authors:  M W Bekkenk; F A Geelen; P C van Voorst Vader; F Heule; M L Geerts; W A van Vloten; C J Meijer; R Willemze
Journal:  Blood       Date:  2000-06-15       Impact factor: 22.113

Review 6.  Refractory celiac disease.

Authors:  B M Ryan; D Kelleher
Journal:  Gastroenterology       Date:  2000-07       Impact factor: 22.682

7.  Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

Authors:  C Cellier; E Delabesse; C Helmer; N Patey; C Matuchansky; B Jabri; E Macintyre; N Cerf-Bensussan; N Brousse
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

8.  Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes.

Authors:  J Spencer; N Cerf-Bensussan; A Jarry; N Brousse; D Guy-Grand; A S Krajewski; P G Isaacson
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

9.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.

Authors:  B Jabri; N P de Serre; C Cellier; K Evans; C Gache; C Carvalho; J F Mougenot; M Allez; R Jian; P Desreumaux; J F Colombel; C Matuchansky; H Cugnenc; M Lopez-Botet; E Vivier; A Moretta; A I Roberts; E C Ebert; D Guy-Grand; N Brousse; J Schmitz; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

10.  Interleukin 15 mediates epithelial changes in celiac disease.

Authors:  L Maiuri; C Ciacci; S Auricchio; V Brown; S Quaratino; M Londei
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

View more
  9 in total

1.  From hyperplasia to T cell lymphoma.

Authors:  N Cerf-Bensussan; N Brousse; C Cellier
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 2.  CD4+ T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue.

Authors:  Jaroslav Zivny; Barbara F Banner; Sanjay Agrawal; German Pihan; Graham F Barnard
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 3.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

Review 4.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

5.  Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.

Authors:  T T Salmi; P Collin; I R Korponay-Szabó; K Laurila; J Partanen; H Huhtala; R Király; L Lorand; T Reunala; M Mäki; K Kaukinen
Journal:  Gut       Date:  2006-03-29       Impact factor: 23.059

Review 6.  Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification.

Authors:  Parwiz J Siaghani; Joo Y Song
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

7.  Reprogramming of CTLs into natural killer-like cells in celiac disease.

Authors:  Bertrand Meresse; Shane A Curran; Cezary Ciszewski; Gerasim Orbelyan; Mala Setty; Govind Bhagat; Leanne Lee; Maria Tretiakova; Carol Semrad; Emily Kistner; Robert J Winchester; Veronique Braud; Lewis L Lanier; Daniel E Geraghty; Peter H Green; Stefano Guandalini; Bana Jabri
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

8.  Type I enteropathy-associated T-cell lymphoma in the colon of a 29-year-old patient and a brief literature review.

Authors:  Jiu-Cong Zhang; Yong Wang; Xiu-Feng Wang; Fang-Xin Zhang
Journal:  Onco Targets Ther       Date:  2016-02-22       Impact factor: 4.147

9.  Refractory Celiac Disease Type II: A Case Report that Demonstrates the Diagnostic and Therapeutic Challenges.

Authors:  Alexandra Fernandes; Ana Margarida Ferreira; Rosa Ferreira; Sofia Mendes; Cláudia Agostinho; Nuno Almeida; Pedro Figueiredo; Manuela Ferreira; Pedro Amaro; Lígia Prado E Castro; Carlos Sofia
Journal:  GE Port J Gastroenterol       Date:  2015-09-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.